drugset / Trial / NCT02975206
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
Timeline
- Start
- 2016-11
- Primary completion
- 2018-01-16
- Completion
- 2018-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Serlopitant | Small molecule | 1 mg | Oral |
| Subject | Serlopitant | Small molecule | 5 mg | Oral |